RxDoctor Payments Data

Kayla Broadway

Family · Walnut Ridge, ARNPI 1467020529

Payments from drug & device makers

$3,384in general payments, 2019–2025

Across 147 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$824
  • AstraZeneca$436
  • Axsome Therapeutics, Inc.$350
  • GSK$312
  • Lilly USA, LLC$299
  • AbbVie$190
  • plus $973 from 16 others

What the payments were for

  • Food & beverage$3,384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,384 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin22$18,096
OzempicSemaglutide16$17,861
MounjaroTirzepatide13$16,956
Tresiba Flextouch U-100Insulin Degludec11$14,649
EliquisApixaban17$8,254
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,882
MyrbetriqMirabegron14$6,192
BelsomraSuvorexant14$6,031
TradjentaLinagliptin11$5,485
Pregabalin22$1,818
Omeprazole34$478
Tramadol Hcl42$452
Atorvastatin Calcium48$398
Albuterol Sulfate HfaAlbuterol Sulfate12$388
Duloxetine Hcl15$283

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$824$17,86116 claims
Lilly USA, LLCMounjaro$299$16,95613 claims
PfizerEliquis$51$8,25417 claims
AstraZenecaBreztri Aerosphere$436$6,88211 claims
Astellas Pharma US IncMyrbetriq$76$6,19214 claims
MerckBelsomra$28$6,03114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Walnut Ridge

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →